Management of Advanced Prostate Cancer

Author:

Auclerc Gerard12,Antoine Eric C.1,Cajfinger Francis1,Brunet-Pommeyrol Arlette2,Agazia Chahrok2,Khayat David1

Affiliation:

1. SOMPS, Salpêtrière Hospital, Department of Medical Oncology, Paris, France

2. Centre Charlebourg, la Garenne-Colombes, France

Abstract

Abstract Most cases of advanced carcinoma of the prostate are hormonosensitive. The use of combined androgen blockade (CAB) seems to improve survival and quality of life, but only when combined with chemical castration by luteinizing-hormone-releasing hormone analog and without the use of steroidal antiandrogens. After CAB, further hormonal treatments remain efficacious, such as antiandrogen withdrawal followed by estrogens, aromatase inhibitors, and hormone-refractory prostate cancer multiple cytotoxic agents. For painful bone lesions, external beam radiotherapy, biphosphonates, and strontium 89 or samarium 153 provide pain relief. The use of new methods for the evaluation of response and quality of life will allow the rapid identification of effective treatments and permit powered phase III trials.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference54 articles.

1. Adenocarcinoma of the prostate: innovations in management;Petrovich;Am J Clin Oncol,1997

2. Cancer statistics, 1996;Parker;CA Cancer J Clin,1996

3. Epidémiologie du cancer de la prostate et ses implications en santé publique;Richard;Rev Prat,1994

4. Cancer statistics, 1999;Landis;CA Cancer J Clin,1999

5. Treatment of progressive metastatic prostate cancer;Dawson;Oncology,1993

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3